Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001084544 | SCV000623280 | likely benign | Bloom syndrome | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000576007 | SCV000672943 | likely benign | Hereditary cancer-predisposing syndrome | 2017-05-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000728499 | SCV000856079 | uncertain significance | not provided | 2017-08-18 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000576007 | SCV002529437 | likely benign | Hereditary cancer-predisposing syndrome | 2020-11-11 | criteria provided, single submitter | curation | |
Natera, |
RCV001084544 | SCV001456634 | likely benign | Bloom syndrome | 2020-09-16 | no assertion criteria provided | clinical testing |